Legend Biotech Corp (LEGN) — Cash Flow Quality Index
Latest as of June 2026:
-0.63x
Legend Biotech Corp (LEGN) has a Cash Flow Quality Index of -0.63x as of June 2026. Operating cash flow of $-20.90 Million is below net income of $33.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore LEGN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.63x
Operating CF / Net Income
Operating Cash Flow
$-20.90 Million
USD
Net Income
$33.20 Million
USD
Data as of
Jun 2026
Most recent filing
Legend Biotech Corp Cash Flow Quality Index (2017–2017)
Historical Cash Flow Quality Index for Legend Biotech Corp across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Legend Biotech Corp cash flow conversion.
Annual Cash Flow Quality Index for Legend Biotech Corp (2017–2017)
Year-by-year earnings quality comparison for Legend Biotech Corp.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | -0.25x | $-2.38 Million | $9.37 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.